000 02642cam a2200313 a 4500
003 EG-GiCUC
008 180609s2017 ua dh f m 000 0 eng d
040 _aEG-GiCUC
_beng
_cEG-GiCUC
041 0 _aeng
049 _aDeposite
097 _aM.Sc
099 _aCai01.09.13.M.Sc.2017.Ha.P
100 0 _aHamdi Ahmed Rageh Ghaleb
245 1 0 _aPlatelet-rich plasma prolotherapy for treatment of temporomandibular joint hypermobility /
_cHamdi Ahmed Rageh Ghaleb ; Supervised Hamida Refai Hassanien , Osama Taema
246 1 5 _aللبلازما الغنية بالصفيحات الدموية Lمعالجة فرط حركة المفصل الفكي الصدغي بالمعالجة المكثرة
260 _aCairo :
_bHamdi Ahmed Rageh Ghaleb ,
_c2017
300 _a97 P. :
_bcharts , facsimiles ;
_c25cm
502 _aThesis (M.Sc.) - Cairo University - Faculty of Oral and Dental Medicine - Department of Oral and Maxillofacial Surgery
520 _aPurpose: the purpose of this study was to assess the efficacy of PRP prolotherapy in patients with symptomatic TMJ hypermobility after single versus double sessions of PRP injections. Patients and methods:Thirty-eight patients with bilateral TMJ hypermobility were included in this study. They were 11 males and 27 females. Their ages ranged from 18- 45 years, with an average of 28.43 ± 6.92years. In group 1, each TMJ received single session of intra-articular and pericapsular injections with 1.5 ml of PRP. While in group 2, each TMJ received two sessions of injection with 2 weeks apart. Clinical outcomes including pain severity on function, according to the visual analog scale (VAS), frequency of luxations, maximal mouth opening (MMO) and clicking sound were measured at baseline and at 6, 12 and 30 weeks after treatment. Results:Both groups showed statistically significant decrease in all the evaluated parameters at the first follow-up interval that maintained thereafter.By the end of the present study, the comparison between the two groups showed significant decrease in pain scores, frequency of luxation and MMO in group 2 compared to group 1. Conclusion: The results of the present study reveal the short-term effectiveness of PRP prolotherapy with double dose of PRP is more effective to alleviate symptoms of TMJ hypermobility than single dose
530 _aIssued also as CD
653 4 _aHypermobility
653 4 _aSubluxation
653 4 _aTemporomandibular joint
700 0 _aHamida Refai Hassanien ,
_eSupervisor
700 0 _aOsama Taema ,
_eSupervisor
905 _aNazla
_eRevisor
905 _aShimaa
_eCataloger
942 _2ddc
_cTH
999 _c66514
_d66514